Smoking prevalence and its influence on disease course and surgery in Crohn's disease and ulcerative colitis

Alimentary Pharmacology and Therapeutics

Volumn 42, Issue 1, 2015, Pages 61-70

  Lunney, P C ^a,b   Kariyawasam, V C ^c   Wang, R R ^a,d   Middleton, K L ^a,c   Huang, T ^e,f   Selinger, C P ^c,g   Andrews, J M ^h   Katelaris, P H ^a,c   Leong, R W L ^a,c,d  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Dubbo Base Hospital   (Australia)

^c ANZAC Research Institute   (Australia)

^d ROYAL NORTH SHORE HOSPITAL   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f ST GEORGE HOSPITAL   (Australia)

^g LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^h ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CORTICOSTEROID; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; IMMUNOSUPPRESSIVE AGENT;

ADULT; ANAMNESIS; ARTHRITIS; ARTICLE; AUSTRALIA; COHORT ANALYSIS; COLON RESECTION; COLON SURGERY; CONTROLLED STUDY; CROHN DISEASE; DEMOGRAPHY; DISEASE COURSE; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PATIENT INFORMATION; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SMOKING; ULCERATIVE COLITIS; ADOLESCENT; COLITIS, ULCERATIVE; EPIDEMIOLOGY; MIDDLE AGED; PROCEDURES; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; COLECTOMY; COLITIS, ULCERATIVE; CROHN DISEASE; DISEASE PROGRESSION; FEMALE; HOSPITALIZATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; SMOKING; YOUNG ADULT;

EID: 84930477136     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13239     Document Type: Article

References (60)

1. Lunney PC, Leong RW,. Review article: ulcerative colitis, smoking and nicotine therapy. Aliment Pharmacol Ther 2012; 36: 997-1008.
2. Samuelsson S,. Ulceroscolitochproktit [dissertation]. Uppsala, Sweden: Department of Social Medicine, University of Uppsala, 1976.
3. Somerville KW, Logan RFA, Edmond M, et al,. Smoking and Crohn's disease. BMJ 1984; 289: 954-6.
4. Boyko EJ, Koepsell TD, Perera DR, Inui TS,. Risk of ulcerative colitis among former and current cigarette smokers. N Engl J Med 1987; 316: 707-10.
5. Bures J, Fixa B, Komarkova O, Fingerland A,. Non-smoking: a feature of ulcerative colitis (letter). Br Med J 1982; 285: 440.
6. Calkins B, Lilienfeld A, Mendeloff A, Garland C, Monk M, Garland F,. Smoking factors in ulcerative colitis and Crohn's disease in Baltimore. Am J Epidemiol 1984; 120: 498.
7. Franceschi S, Panza E, La Vecchia C, Parazzini F, DeCarli A, Porro GB,. Nonspecific inflammatory bowel disease and smoking. Am J Epidemiol 1987; 125: 445-52.
8. Harries AD, Jones L, Heatley RV, Rhodes J,. Smoking habits and inflammatory bowel disease: effect on nutrition. Br Med J 1982; 284: 1161.
9. Jick H, Walker AM,. Cigarette smoking and ulcerative colitis. N Engl J Med 1983; 308: 261-3.
10. Lindberg E, Tysk C, Andersson K, Järnerot G,. Smoking and inflammatory bowel disease. A control study. Gut 1988; 29: 352-7.
11. Logan RFA, Edmond M, Somerville KW, Langman MJS,. Smoking and ulcerative colitis. Br Med J 1984; 288: 751-3.
12. Thornton JR, Emmett PM, Heaton KW,. Smoking, sugar, and inflammatory bowel disease. Br Med J 1984; 288: 362.
13. Tobin MV, Logan RFA, Langman MJS, McConnel RB, Gilmore IT,. Cigarette smoking and inflammatory bowel disease. Gastroenterology 1987; 93: 316-21.
14. Calkins BM,. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 1989; 34: 1841-54.
15. Aldhous MC, Drummond HE, Anderson N, et al,. Smoking habit and load influence age at diagnosis and disease extent in ulcerative colitis. Am J Gastroenterol 2007; 102: 589-97.
16. Benoni C, Nilsson A,. Smoking habits in patients with inflammatory bowel disease. Scand J Gastroenterol 1984; 19: 824-30.
17. Motley RJ, Rhodes J, Kay S, et al,. Late presentation of ulcerative colitis in ex-smokers. Int J Colorectal Dis 1988; 3: 171-5.
18. Srivasta ED, Newcombe RG, Rhodes J,. Smoking and ulcerative colitis: a community study. Int J Colorectal Dis 1993; 8: 71-4.
19. Beaugerie L, Massot N, Carbonnel F, et al,. Impact of cessation of smoking on the course of ulcerative colitis. Am J Gastroenterol 2001; 96: 2113-6.
20. van der Heide F, Dijkstra A, Weersma RK, et al,. Effects of active and passive smoking on disease course ofCrohn's disease and ulcerative colitis. Inflamm Bowel Dis 2009; 15: 1199-207.
21. Boyko EJ, Perera DR, Koepsell TD, et al,. Effects of cigarette smoking on the clinical course of ulcerative colitis. Scand J Gastroenterol 1988; 23: 1147-52.
22. Green JT, Rhodes J, Ragunath K, et al,. Clinical status of ulcerative colitis. Am J Gastroenterol 1998; 93: 1463-7.
23. Höie O, Wolters F, Riis L, et al,. Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a European-wide population-based cohort. Am J Gastroenterol 2007; 102: 1692-701.
24. Odes HS, Fich A, Reif S, et al,. Effects of current cigarette smoking on clinical course of Crohn's disease and ulcerative colitis. Dig Dis Sci 2001; 46: 1717-21.
25. Cosnes J,. Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice. Best Pract Res ClinGastroenterol 2004; 18: 481-96.
26. Fraga XF, Vergara M, Medina C, et al,. Effects of smoking on the presentation and clinical course of inflammatory bowel disease. Eur J Gastroenterol Hepatol 1997; 9: 683-7.
27. Holdstock G, Savage D, Marman M, et al,. Should patients with inflammatory bowel disease smoke? Br Med J 1984; 288: 362.
28. Cosnes J, Carbonnel F, Beaugerie L, et al,. Effects of cigarette smoking on the long-term course of Crohn's disease. Gastroenterology 1996; 110: 424-31.
29. Cottone M, Rosselli M, Orlando A, et al,. Smoking habits and recurrence in Crohn's disease. Gastroenterology 1994; 106: 643-8.
30. Duffy LC, Zielezny MA, Marshall JR, et al,. Cigarette smoking and risk of clinical relapse in patients with Crohn's disease. Am J Prev Med 1990; 6: 161-6.
31. Timmer A, Sutherland LR, Martin F,. Oral contraceptive use and smoking are risk factors for relapse in Crohn's disease: the Canadian mesalamine for remission of Crohn's disease study group. Gastroenterology 1998; 114: 1143-50.
32. Cosnes J, Beaugerie L, Carbonnel F, et al,. Smoking cessation and the course of Crohn's disease: an intervention study. Gastroenterology 2001; 120: 1093-9.
33. Russel MG, Volovics A, Schoon EJ, et al,. Inflammatory bowel disease: is there any relation between smoking status and disease presentation? European Collaborative IBD Study Group Inflamm Bowel Dis 1998; 4: 182-6.
34. Nunes T, Etchevers MJ, Domènech E, et al,. Smoking does influence disease behaviour and impacts the need for therapy in Crohn's disease in the biologic era. Aliment Pharmacol Ther 2013; 38: 752-60.
35. Gustavsson A, Magnuson A, Blomberg B, et al,. Smoking is a risk factor for recurrence of intestinal stricture after endoscopic dilation in Crohn's disease. Aliment Pharmacol Ther 2013; 37: 430-7.
36. De Cruz P, Kamm MA, Hamilton AL, et al,. Crohn's disease management after intestinal resection: a randomised trial. Lancet 2014; 385: 1406-17.
37. Aldhous MC, Drummond HE, Anderson N, et al,. Does cigarette smoking influence the phenotype of Crohn's disease? Analysis using the Montreal Classification. Am J Gastroenterol 2007; 102: 577-88.
38. Cosnes J, Cattan S, Blain A, et al,. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002; 8: 244-50.
39. Nunes T, Etchevers MJ, Merino O, et al,. Does smoking influence Crohn's disease in the biologic era? The tabacrohn study Inflamm Bowel Dis 2013; 19: 23-9.
40. Selinger CP, Andrews J, Dent OF, et al,. Cause-specific mortality and 30-year relative survival of Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2013; 19: 1880-8.
41. Selinger CP, Andrews JM, Titman A, et al,. Long-term follow-up reveals low incidence of colorectal cancer, but frequent need for resection, among Australian patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2014; 12 (4): 644-50.
42. Kariyawasam VC, Selinger CP, Katelaris PH, et al,. Early use of thiopurines or methotrexate reduces major abdominal and perianal surgery in Crohn's disease. Inflamm Bowel Dis 2014; 20: 1382-90.
43. New South Wales Ministry of Health, Report of the Chief Health Officer, 2013 Health Statistics of Sydney Local Health District, New South Wales, Australia. Available at: http://www.healthstats.nsw.gov.au/indicator/dem-pop-lhnmap (accessed 3 March 2015).
44. Tan M, Holloway RH, Lange K, Andrews JM,. General practitioners' knowledge of and attitudes to inflammatory bowel disease. Intern Med J 2012; 42: 801-7.
45. Lennard-Jones JE,. Classification of inflammatory bowel disease. Scand J Gastroenterol 1989; 170: 2-6.
46. Truelove SC, Witts LJ,. Cortisone in ulcerative colitis: final report of therapeutic trial. Br Med J 1955; 2: 1041-8.
47. Silverberg MS, Satsangi J, Ahmad T, et al,. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montréal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19 (Suppl A): 5A-36A.
48. Campuzano JC, Hernandez-Avila M, Jaakkola MS, et al,. Determinants of salivary cotinine levels among current smokers in Mexico. Nicotine Tob Res 2004; 6: 997-1008.
49. Danese S, Sans M, Fiocchi C,. Inflammatory bowel disease: the role of environmental factors. Autoimmun Rev 2004; 3: 394-400.
50. Lawrence IC, Murray K, Batman B, et al,. Crohn's disease and smoking: is it ever too late to quit? J Crohns Colitis 2013; 7: 665-71.
51. Barreiro-de Acosta M, Dominguez-Munoz JE, Nunez-Pardo de Vera MC, et al,. Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations. Eur J Gastroenterol Hepatol 2007; 19: 73-8.
52. Lakatos PL, Szalay F, Tulassay Z, et al,. Clinical presentation of Crohn's disease. Association between familial disease, smoking, disease phenotype, extraintestinalmaifestations and need for surgery. Hepato-Gastroenterol 2005; 52: 817-22.
53. Roberts H, Rai SN, Pan J, et al,. Extraintestinal manifestations of inflammatory bowel disease and the influence of smoking. Digestion 2014; 90: 122-9.
54. Veloso FT, Carvalho J, Magro F, et al,. Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J Clin Gastroenterol 1996; 23: 29-34.
55. Domenech E, Carrion S, Garcia-Planella E, et al,. Smoking status and response to thiopurines in steroid-dependent inflammatory bowel disease. Inflamm Bowel Dis 2011; 17: 971-5.
56. Moum B, Ekbom A, Vatn MH, et al,. Clinical course during the 1st year after diagnosis in ulcerative colitis and Crohn's disease. Results of a large, prospective population-based study in southeastern Norway, 1990-93. Scand J Gastroenterol 1997; 32: 1005-12.
57. Silicia B, Vicente R, Arroyo MT, et al,. Ulcerative pancolitis predicts the need for colectomy: study of an incident cohort of patients with ulcerative colitis in Aragon (Spain). Gastroenterol Hepatol 2005; 28: 55-9.
58. Morales NA, Romano MA, Michael Cummings K, et al., Accuracy of self-reported tobacco use in newly diagnosed cancer patients. Cancer Causes Control 2013; 24: 1223-30.
59. Haye Salinas MJ, Retamozo S, Alvarez AC, et al., Effects of cigarette smoking on early arthritis: a cross-sectional study-data from the Argentine Consortium for Early Arthritis (CONAART). Rheumatol Int 2015; 35: 855-9.
60. Vegh Z, Golovics PA, Lovasz BD, et al., Low incidence of venous thromboembolism in inflammatory bowel diseases: prevalence and predictors from a population-based inception cohort. Scand J Gastroenterol 2015; 50: 306-11.